SGTX - Sigilon Therapeutics GAAP EPS of -$0.21 beats by $0.17 revenue of $2.64M misses by $0.03M March, 14 2023 04:53 PM Sigilon Therapeutics Inc. 2023-03-14 16:53:16 ET Sigilon Therapeutics press release ( NASDAQ: SGTX ): Q4 GAAP EPS of -$0.21 beats by $0.17 . Revenue of $2.64M (+32.7% Y/Y) misses by $0.03M . For further details see: Sigilon Therapeutics GAAP EPS of -$0.21 beats by $0.17, revenue of $2.64M misses by $0.03M